Why review articles on the health effects of passive smoking reach different conclusions

JAMA

Volumn 279, Issue 19, 1998, Pages 1566-1570

  Barnes, Deborah E ^a,b   Bero, Lisa A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDICAL LITERATURE; OUTCOMES RESEARCH; PASSIVE SMOKING; PRIORITY JOURNAL; PUBLICATION; REVIEW; TOBACCO INDUSTRY;

EID: 0032550671     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.279.19.1566     Document Type: Review

References (48)

1. US Environmental Protection Agency. Respiratory Health Effects of Passive Smoking: Lung Cancer and Other Disorders. Washington, DC: US Environmental Protection Agency; 1992.
2. US Department of Health and Human Services. The Health Consequences of Involuntary Smoking: A Report of the Surgeon General. Rockville, Md: US Public Health Service; 1986.
3. National Academy of Sciences. Environmental Tobacco Smoke: Measuring Exposures and Assessing Health Effects. Washington, DC: National Academy Press; 1986.
4. O'Neill IK, Brunnemann KD, Dodet B, Hoffmann D, eds. Passive Smoking: Environmental Carcinogens Lyon, France: International Agency for Research on Cancer; 1987. IARC scientific publications, No. 81, vol 9.
5. Wells AJ. Passive smoking as a cause of heart disease. J Am Coll Cardiol. 1994;24:546-554.
6. Glantz S, Parmley W. Passive smoking and heart disease: mechanisms and risks. JAMA. 1995;273: 1047-1053.
7. DiFranza JR, Lew RA. Effect of maternal cigarette smoking on pregnancy complications and sudden infant death syndrome. J Fam Pract. 1995;40:385-394.
8. Bero LA, Galbraith A, Rennie D. Sponsored symposia on environmental tobacco smoke. JAMA. 1994;271:612-617.
9. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of the results of meta-analyses of randomized control trials and recommendations of clinical experts. JAMA. 1992;268:240-248.
10. Silagy CA. An analysis of review articles published in primary care journals. Fam Pract. 1993; 10:337-341.
11. Mulrow CD. The medical review article: state of the science. Ann Intern Med. 1987;106:485-488.
12. Oxman AD, Guyatt GH. Guidelines for reading literature reviews. Can Med Assoc J. 1988;138:697-703.
13. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA Chalmers TC. Meta-analyses of randomized controlled trials. N Engl J Med. 1987;316:450-455.
14. Mulrow CD. Rationale for systematic reviews. BMJ. 1994;309:597-599.
15. Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med. 1997;126:376-380.
16. Haynes RB. Clinical review articles: should be as scientific as the articles they review. BMJ. 1992; 304:330-331.
17. Rochon PA, Gurwitz JH, Cheung M, Hayes JA, Chalmers TC. Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal. JAMA. 1994;272:108-113.
18. Barnes DE, Bero LA. Scientific quality of original research articles on environmental tobacco smoke. Tob Control. 1997;6:19-26.
19. Barnes DE, Bero LA. Industry-funded research and conflict of interest: an analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research. J Health Polit Policy Law. 1996;21:515-542.
20. Cho MK, Bero LA. The quality of drug studies published in symposium proceedings. Ann Intern Med. 1996;124:485-489.
21. Rochon PA, Gurwitz JH, Simms RW, et al. A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med. 1994;154:157-163.
22. Gotzsche PC. Methodology and overt and hidden bias in reports of 196 double-blind trials of non-steroidal antiinflammatory drugs in rheumatoid arthritis. Controlled Clin Trials. 1989;10:31-56.
23. Davidson RA. Source of funding and outcomes of clinical trials. J Gen Intern Med. 1986;1:155-158.
24. Swaen GMH, Meijers JMM. Influence of design characteristics on the outcome of retrospective cohort studies. Br J Ind Med. 1988;45:624-629.
25. Assendelft WJJ, Koes BW, Knipschild PG, Bouter LM. The relationship between methodological quality and conclusions in reviews of spinal manipulation. JAMA. 1995;274:1942-1948.
26. Chalmers TC, Frank CS, Reitman D. Minimizing the three stages of publication bias. JAMA. 1990; 263:1392-1395.
27. Mulrow CD, Oxman A. How to Conduct a Cochrane Systematic Review. San Antonio, Tex: Cochrane Collaboration; 1996.
28. Oxman AD, Guyatt GH, Singer J, et al. Agreement among reviewers of review articles. J Clin Epidemiol. 1990;44:91-98.
29. Oxman AD, Guyatt GH. Validation of an index of the quality of review articles. J Clin Epidemiol. 1991;44:1271-1278.
30. Light RJ, Pillemar DB. Summing Up: The Science of Reviewing Research. Cambridge, Mass: Harvard University Press; 1984.
31. Bland JM, Altman DG. Comparing two methods of clinical measurement: a personal history. Int J Epidemiol. 1995;24:S7-S14.
32. Glantz SA, Slade J, Bero LA, Hanauer P, Barnes DE. The Cigarette Papers. Berkeley: University of California Press; 1996.
33. Bero LA, Glantz SA. Tobacco industry response to a risk assessment of environmental tobacco smoke. Tob Control. 1993;2:103-113.
34. Tong S, McMichael AJ. Maternal smoking and neuropsychological development in childhood: a review of the evidence. Dev Med Child Neurol. 1992; 34:191-197.
35. Tredaniel J, Boffetta P, Little J, Saracci R, Hirsch A. Exposure to passive smoking during pregnancy and childhood, and cancer risk: the epidemiological evidence. Paediatr Perinatol Epidemiol. 1994;8:233-255.
36. Shimizu Y, Namekata T, Takemoto K. Epidemiological issues on involuntary smoking and lung cancer. In: Kasuga H, ed. Indoor Air Quality. New York NY: Springer-Verlag; 1990:323-332.
37. Rubin DH, Damus K. The relationship between passive smoking and child health: methodologic criteria applied to prior studies. Yale J Biol Med. 1988; 61:401-411.
38. Tager IB. Health effects of in voluntary smoking in the workplace. N Y State J Med. 1989;89:27-31.
39. Tredaniel J, Boffetta P, Saracci R, Hirsch A. Exposure to environmental tobacco smoke and adult non-neoplastic respiratory diseases. Eur Respir J. 1994;7:173-185.
40. Saracci R. Passive smoking and lung cancer. In: Zaridze DG, Peto R, eds. Tobacco: A Major International Health Hazard. Lyon, France: International Agency for Research on Cancer; 1986:173-182.
41. Blakley BW, Blakley JE. Smoking and middle ear disease: are they related? a review article. Otolaryngol Head Neck Surg. 1995;112:441-446.
42. Crawford WA. On the health effects of environmental tobacco smoke. Arch Environ Health. 1988; 43:34-37.
43. Armitage AK. Environmental tobacco smoke and coronary heart disease. J Smok Relat Disord. 1993;4:27-36.
44. Law MR, Morris JK, Wald NJ. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ. 1997;315:973-980.
45. Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ. 1997;315:980-988.
46. Bero L, Barnes D, Hanauer P, Slade J, Glantz S. Lawyer control of the tobacco industry's external research program. JAMA. 1995;274:241-247.
47. Barnes D, Hanauer P, Slade J, Bero L, Glantz S. Environmental tobacco smoke. JAMA. 1995;274:248-253.
48. Durbin R. The tobacco industry strategy: new subject, same tactics. Tob Control. 1993;2:8-9.